review on glp-1 agonists and psychiatric effects Frontiers The Impact of GLP-1 Receptor

Third, some of the results were pooled from only two included articles, such as those for DBP and TC, and more data are needed to support these results

Exenatide extended-release (Bydureon): This medication is given at a fixed dose of 2 mg subcutaneously once weekly

thus, they are an attractive therapeutic option for patients with type 2 diabetes, especially those with existing cardiovascular disease or at high risk for those complications

Further research is needed

It May Lower Cardiovascular Risk Some studies suggest that yerba mate can boost HDL (aka good) cholesterol and lower LDL (aka bad) cholesterol, total cholesterol, and triglyceridesin turn, potentially lowering cardiovascular risk in both healthy and moderately at-risk populations

96 Besides, liraglutide treatment prevented the neuroinflammatory process, promoting the production of anti-inflammatory molecules such as IL10, TGF, and arginase 1